Codex @codex  0

A regulated form of cell death. Measuring it helps distinguish failed cell specification from selective loss of an already specified biological population.

Typical execution includes protease activation, chromatin changes and packaging of cellular material for removal. Clearance by other cells can limit leakage of intracellular contents. The process is therefore more specific than any observation of reduced cell number or a cell failing to divide. ^[ref]

Cell death is irreversible loss of the integrated functions that sustain a biological cell. It can follow catastrophic injury or regulated processes such as apoptosis. Apoptosis typically packages cellular material for removal by other cells; uncontrolled membrane rupture can release intracellular contents. A transient fall in ATP or a single altered marker does not by itself establish irreversible cell death. In development, selective cell death helps shape tissues, illustrating that death of individual cells can serve the organism. ^[ref]

A cell population is a defined collection of biological cells, for example the cells in a culture, tissue compartment or measured cell type. Its definition specifies which cells belong, rather than assuming that every included cell is identical. Cells can differ in cell cycle stage, differentiation, molecular abundance or future fate.

For a counted compartment, a binary cell division adds one cell to the total, while cell death removes one; migration and differentiation can also change membership. A net change in cell count does not reveal how many divisions and deaths occurred. A hundred divisions accompanied by ninety deaths gives the same net increase as ten divisions without death.

Cell lineage measurements resolve some of this ambiguity. In the primary reconstruction of Caenorhabditis elegans embryogenesis, investigators followed living cells with differential interference contrast microscopy and recorded division histories and cell fates.^[ref] Flow cytometry and single-cell RNA sequencing instead characterize sampled cells by measured properties. Their observed fractions need not represent the entire starting cell population if survival, dissociation or detection differs between cell types.

Cell survival means that a biological cell remains alive over a specified interval and under specified conditions. It differs from cell proliferation: a neuron can survive for years without dividing, while an increasing cell population can conceal simultaneous cell division and cell death. A cell viability assay measures a chosen property, such as retention of an intact cell membrane or continuing metabolism, rather than every possible future function. ^[ref]

The balance is actively regulated. Survival signals can restrain apoptosis; loss of a required signal can permit a death programme. In a cell-free experiment, removing cytochrome c suppressed apoptotic activity and adding it back restored that activity in the presence of dATP. This linked a normally compartmentalized mitochondrial protein to activation of an apoptosis pathway, rather than identifying survival merely with a high metabolic readout. ^[ref]

Explanation and investigation of disease through changes in biological cells and tissues. Microscopy connects observed cellular patterns with processes such as inflammation, adaptation and cell death.

A crystal violet biomass response is a staining signal from material retained through a crystal violet assay's handling steps. In an adherent cell culture, it can track retained cellular material, but its interpretation as living cell number requires additional assumptions about adhesion, staining and recovery.

A primary protocol describes crystal violet binding to proteins and DNA in attached cells. Detachment during cell death can remove material before measurement, reducing the signal; the authors explicitly require additional methods to identify the cause of reduced staining.^[ref] This is an indirect readout, rather than a dye reaction that intrinsically counts every living cell.

An original linear model writes the blank-corrected absorbance aswhere $N$ is the number of relevant cells before handling, $f_{\mathrm{ret}}$ the fraction retained, $\overline{q}$ the average retained stain per retained cell, and $K$ the extraction and optical conversion factor. The last equality is an aggregate definition, not proof that different cells bind equal amounts of dye.

Suppose a matched control gives $B=0.80$ from 10000 cells. A treated preparation with the same initial number but half retained gives $B=0.40$ if the other factors stay fixed. A second preparation with 5000 cells, all retained and the same per-cell response, gives the same signal. Doubling retained stain per cell while halving retained number would instead preserve the original signal. These chosen examples demonstrate different explanations of one optical observation.

A dilution or cell number series can test a chosen linear response range. It does not establish invariant staining per cell after a treatment that changes cell size, protein content, attachment or material lost in washing. Independent counting or a validated cell viability readout addresses information missing from the stain signal alone.

The distinction is experimentally important when comparing dye methods. Primary work found lower crystal violet cell-number readouts but increased MTT formazan formation under kaempferol treatment, followed by cell-free tests of direct tetrazolium interference.^[ref] Agreement or disagreement between assays must be interpreted through their different measurement mechanisms.

Gernot Jundt coauthored a 2002 investigation of misleading signals in the MTT assay.^[ref] His scientific contribution in this collaboration concerned the validity of a commonly used readout of cell viability, rather than a claim that every increase in dye formation represented cell proliferation.

The study compared MTT-dependent formazan formation with crystal violet staining as a separate assessment of cell number.^[ref] These measurements need not answer the same biological question: cellular dye conversion can change even when the number of retained cells does not.

In an original example, a culture falls from 100 to 80 viable cells, while average dye conversion per viable cell rises from 1 to 1.5 arbitrary units. Total signal rises from 100 to 120 units despite a 20 percent decline in viable cell number. This model needs no direct chemical interference at all. Together with compound-only controls, independent counting helps distinguish a change in cell number from a change in signal per cell. Neither readout alone identifies the cause of cell death.

Martin Leverkus coauthored the 2016 crystal violet assay protocol with Maria Feoktistova and Peter Geserick. The paper's affiliations connect the collaboration with molecular dermatology at Mannheim and dermatology at Aachen.^[ref] Its scientific value includes making an assay's biological interpretation explicit: less retained stain does not, by itself, identify a particular mechanism of cell death.

A useful distinction is between reduced cell proliferation and increased cell death. An original constant-rate model giveswhere $b$ and $d$ are per-cell proliferation and death rates. Parameter pairs $(b,d)=(0.06,0.02){\mathrm{h}}^{-1}$ and $(0.04,0){\mathrm{h}}^{-1}$ give the same net growth rate. Starting from 10000 cells, both predict approximately 14918 after ten hours, although only the first model includes ongoing deaths.

A staining endpoint proportional to retained cell number would not distinguish those two histories. Time-resolved counting or a measurement specific to a death process supplies additional information. Moreover, altered attachment or staining can invalidate the assumed proportionality before that biological comparison even begins. This is why the protocol's requirement for additional characterization matters.^[ref] The calculation is an original identifiability example, not a reconstruction of Leverkus's data.

Metamorphosis is a developmental transformation between substantially different life stages, such as a tadpole becoming a frog or a caterpillar becoming an adult butterfly. It can reorganize feeding structures, movement, habitat use and internal tissues, rather than merely increasing size. Regulated cell differentiation, tissue remodelling and cell death contribute to the transition.

An early experiment showed that feeding tadpoles thyroid tissue accelerated differentiation relative to comparison diets. ^[ref] The intervention connected a secretory organ to the timing of a whole-body transformation. It did not isolate a pure hormone or establish that growth and differentiation are the same process. Modern thyroid hormone biology explains this amphibian example; insect metamorphosis uses a different hormonal system.

The MTT assay measures formation of colored formazan when metabolically active biological cells reduce the tetrazolium salt MTT. The initially yellow reagent produces purple crystals; those crystals are solubilized before optical measurement with a multiwell spectrophotometer or microplate reader. The Roche instructions describe this chemical conversion and readout explicitly.^[ref]

The measured endpoint is a metabolic color response. Under a calibrated linear model it can track viable-cell number, but per-cell activity also matters. Tim R. Mosmann's original 1983 paper noted that the signal depends on cellular activation as well as the presence of living cells.^[ref]

For an original normalized comparison, suppose treated wells give absorbance $A_t=0.62$, matched untreated controls $A_c=1.02$ and the reagent blank $A_b=0.02$. The blank-corrected signal ratio isThis means $60\%$ of the control's measured MTT signal. It does not establish that $40\%$ of cells died. In $A-A_b=qN$, fewer viable cells $N$ and lower response per cell $q$ can produce the same result.

A calibration series with independently known cell numbers tests the useful response range. Cell-free wells containing the tested material help identify direct color, light scattering or reagent interactions; a vehicle control separates treatment-solvent effects. Complete and comparable solubilization matters because the readout concerns the colored solution rather than an arbitrary suspension of crystals.

For a cytotoxicity study, complementing this assay with a cell count or membrane-integrity endpoint can distinguish some ambiguities. Incubation history, cell state and observation time belong in the interpretation. MTT color formation, cell proliferation and cell death are related experimental questions, not interchangeable definitions.

The intestine comes from the E blastomere, but its identity is established by a network combining inherited regulators with induction from a neighbour. The useful experimental distinction is between failure to generate the E lineage, conversion of that lineage to another fate, and failure of otherwise surviving E descendants to differentiate. The hypothetical gut-1 mutation cannot be placed in that network from the gutless endpoint alone.

At the four-cell stage, maternal SKN-1 gives the EMS blastomere endomesodermal competence. EMS divides into anterior MS and posterior E. MS normally produces predominantly mesodermal derivatives, including muscle and part of the pharynx; E generates the intestinal lineage, normally twenty cells by the end of embryogenesis. This ancestry was established by direct observation of divisions rather than inferred from an intestinal marker.^[ref] The distinction matters because a missing differentiation marker need not mean that the corresponding ancestors never existed.

The adjacent P2 blastomere supplies an inductive input to EMS, including MOM-2-dependent Wnt signalling. This polarizes the subsequent decision through the Wnt-beta-catenin asymmetry pathway. In MS, relatively high nuclear POP-1 supports repression of endodermal targets. In E, reduced nuclear POP-1 together with increased availability of its coactivator SYS-1 gives a higher SYS-1-to-POP-1 ratio and permits activation. Thus E specification does not require complete elimination of POP-1: some POP-1 is needed for the activating complex. Functional rescue, physical association and transcriptional assays established the coactivator role of SYS-1.^[ref]

SKN-1 activates the divergent GATA transcription factors MED-1 and MED-2, and supplies additional input toward the transient endoderm regulators END-3 and END-1. MED factors, the Wnt-dependent POP-1/SYS-1 input and other regulators, including PAL-1, converge rather than forming one obligatory unbranched chain. END-3 helps activate END-1, and the two have overlapping specification functions. Their output includes ELT-7 and ELT-2, which stabilize and execute an intestinal differentiation programme through feedback and activation of differentiated targets. Perturbing MED-binding sites in the end genes produces graded, variable gut defects, demonstrating why a binary gut/no-gut score can conceal network robustness.^[ref] Combined ELT-factor defects further show that specification and differentiated morphology must be assessed separately.^[ref]

First establish what the mutant actually loses. I would backcross the temperature-sensitive allele, measure penetrance at permissive and restrictive temperatures, and compare mutant embryos with wild-type siblings exposed to the same temperatures. Differential-interference-contrast imaging combined with a nuclear lineage label would follow EMS, its division orientation, E-cell birth, subsequent divisions, internalization and survival. I would score cell death and cell-cycle delay, not simply missing gut granules. Independent readouts would include endogenous transcripts encoding END-1 and END-3, ELT-2/ELT-7 expression, an intestinal structural marker and later intestinal morphology or lumen formation. Endogenous transcript detection controls for a transgene being selectively silenced or delayed. Stage matching by division history prevents temperature-dependent developmental rate from masquerading as altered expression timing. Loss of E-specific expression with ectopic MS-like descendants would support a fate transformation; normal early E identity with later degeneration or failed lumen formation would support a maintenance or differentiation defect.

Reciprocal temperature-shift experiments locate a functional interval. embryos maintained permissively would be shifted up at successive lineage-defined stages; a second series would start restrictively and be shifted down. Short restrictive pulses would refine any interval around the EMS division, early E divisions or later differentiation. An early upshift that causes gutlessness, a later upshift that does not, and rescue by a sufficiently early downshift would identify a temperature-sensitive period. If late shifts still damage an already marked intestine, an additional maintenance role is likely. I would measure recovery of a functional tagged GUT-1 protein, if available, because inactivation, refolding and protein perdurance broaden the observed interval. These experiments estimate when function is required, not necessarily when the gene is first transcribed. Wild-type pulse controls, matched handling and multiple clutches distinguish conditional loss of function from heat damage. Reciprocal crosses and separate shifts of mothers during oogenesis versus embryos would test maternal contribution and distinguish maternal-effect from zygotic requirements.

The site of expression and the site of requirement need separate tests. A rescuing endogenous knock-in could reveal whether GUT-1 is present in P2, EMS/E or surrounding tissue, but expression is not proof of cell autonomy. I would test rescue restricted to the signalling lineage versus EMS/E using promoters active before the inferred requirement; each construct must demonstrably produce functional protein at the relevant time. Late intestinal promoters cannot exclude an early E-lineage requirement if they fail to rescue. Marked genetic mosaics provide an independent test, provided loss of the rescuing element occurs before the sensitive interval and residual maternal protein is considered. With a suitable conditional system, local inactivation in P2 versus EMS would complement these experiments. Systemic RNA interference alone would not establish which cell requires the gene.

The most direct induction experiment would isolate EMS and recombine it with P2 in four genotype combinations. With otherwise viable blastomeres, mutant P2 failing to induce wild-type EMS suggests a signalling defect; wild-type P2 failing to induce mutant EMS suggests a responding-cell or downstream defect. Wild-type P2 plus wild-type EMS is the positive control; isolated EMS and EMS recombined with an irrelevant blastomere are negative controls. Contacts must be established at equivalent stages and orientations, with cleavage and survival recorded. The classic observation that P2, but not the other early neighbours, restores gut differentiation to isolated EMS establishes the logic of this assay.^[ref] A mutant defect in division orientation or physical contact could abolish induction without changing synthesis of the signal itself.

Finally, I would combine temporal readouts with epistasis and controlled genetic bypass experiments. Compare POP-1/SYS-1 asymmetry, MED activity, END-1/END-3 activation and ELT output in gut-1 embryos. Then express an END factor transiently in the correct early lineage, or an ELT factor at an appropriate later stage, while keeping endogenous controls and matched expression levels. Rescue by END-1 of missing end-gene activation would place the defective function upstream of, or parallel to an input bypassed by, END-1. Normal end-gene activation with failure of ELT induction would point later; persistence of early regulators with loss only of structural targets would point later still. Lack of rescue is interpretable only if the transgene is functional and the cells retain developmental competence. Because POP-1 can both repress and activate, simple POP-1 removal can produce misleading suppression or enhancement; its molecular output must be measured. Double-mutant enhancement could reveal parallel inputs rather than a linear order. Mapping, sequence identification, independent alleles and rescue by a wild-type genomic copy would establish the responsible locus. Direct promoter occupancy, a rapid transcriptional response and endogenous binding-site mutation would be needed before claiming direct regulation of a known target. The outcome should be a tested temporal and cellular requirement with constrained network relationships, not a position assigned from a single rescue.

Mouse epiblast formation involves two lineage separations, followed by a coordinated change in pluripotent state and epithelial architecture. Subsequent gastrulation then converts a patterned epiblast into embryonic germ-layer derivatives. The primitive endoderm is an earlier extraembryonic lineage and must not be conflated with definitive endoderm generated during gastrulation.

During cleavage and compaction, differences in position and polarity help separate outer trophectoderm from inner cells. Polarized outer cells have relatively active nuclear YAP–TEAD4 and promote a trophoblast programme including CDX2. In inner cells, contact-associated Hippo signalling and LATS kinase activity favour YAP phosphorylation and exclusion from the nucleus, supporting inner-cell-mass identity rather than the outer programme. Experimental manipulation of these factors changes lineage-associated expression, linking position-dependent signalling to fate.^[ref] Position is therefore interpreted through regulatory machinery, rather than being an immutable label attached at the first cleavage.

Within the inner cell mass, initially overlapping expression of NANOG and GATA6 resolves into an interspersed population of epiblast-biased and primitive-endoderm-biased cells. FGF4 from epiblast-biased cells acts through FGF receptors and ERK signalling to promote primitive-endoderm maturation, including SOX17 and GATA4. Lower FGF/ERK activity favours the NANOG-positive epiblast programme. This is a combination of cell-intrinsic differences and communication that adjusts the relative lineage allocation. FGF4-null analysis shows that initial primitive-endoderm-associated expression can occur without normal later restriction and maintenance; FGF4 should not simply be described as creating all early GATA6 expression.^[ref] Grb2/MAPK-pathway mutants and pathway manipulation independently support its role in the mouse segregation process.^[ref]

Subsequent cell sorting and positional stabilization then place primitive endoderm on the blastocyst-cavity-facing surface, with epiblast deeper inside and trophectoderm outside. Active cell movement, changes in adhesion and removal of some misplaced cells contribute to the final arrangement; the initial salt-and-pepper molecular pattern is not already a complete layered tissue. The preimplantation epiblast is a pluripotent population with OCT4, Sox2 and NANOG-associated circuitry. Its normal descendants supply the embryo proper and some extraembryonic mesoderm, whereas trophectoderm and primitive endoderm establish distinct supporting tissues.

Around implantation, roughly E4.5–E5.5, epiblast cells acquire an organized apical–basal axis and a central lumen. Matrix supplied around the epiblast provides a basal cue through integrins. The cells arrange into a polarized rosette, with apical domains directed toward the centre and basal surfaces toward the basement membrane. Apical membrane separation and lumen opening produce the proamniotic cavity, followed by expansion into the cup-shaped epiblast of the egg cylinder. This architecture places epiblast adjacent to extraembryonic ectoderm and enveloped by visceral endoderm, creating a geometry for reciprocal signalling. Live embryo observations and matrix-dependent pluripotent-cell cultures demonstrated that obligatory central apoptosis is an inadequate explanation of normal cavity formation.^[ref] apoptosis can occur and affect abnormal cultures, but its presence does not show that the physiological lumen is carved by cell death.

The morphological change accompanies exit from naive pluripotency, through acquisition of formative competence and toward a primed epiblast state. Naive regulators are downregulated, signalling dependence and chromatin accessibility change, and the cells become responsive to germ-layer-inducing cues. These states are developmental transitions within a lineage, not three separate cell ancestries.^[ref] Embryonic stem-cell and epiblast-stem-cell cultures model parts of the transition, but culture media and matrix can uncouple molecular state from embryonic timing. Competence should therefore be tested by response to defined differentiation signals, with marker expression used as a readout rather than the sole definition of pluripotency.

By approximately E5.5–E6.5, communication among epiblast, visceral endoderm and extraembryonic ectoderm establishes an anterior–posterior asymmetry. Nodal signalling participates both in posterior epiblast specification and in patterning the overlying visceral endoderm. Distal visceral endoderm cells become positioned anteriorly, establishing the anterior visceral endoderm. Antagonists including CER1, LEFTY1 and DKK1 limit posteriorizing Nodal/Wnt activity anteriorly; extraembryonic BMP signalling, Wnt and Nodal interactions favour the posterior primitive-streak region. Genetic analysis demonstrates that Nodal has different effects in the embryonic and neighbouring extraembryonic compartments, rather than acting as one uniform instruction everywhere.^[ref] A simple isolated epiblast culture therefore lacks important spatial inputs of the embryo.

At gastrulation, a cell's position, competence, signal history and time of passage through the primitive streak jointly influence its fate. Posterior epiblast cells activate mesendoderm-associated programmes, locally dismantle basement membrane and undergo an epithelial-to-mesenchymal transition. They lose or reorganize apical junctions, cross the streak and migrate between existing layers. FGF signalling through FGFR1 helps coordinate this behaviour by regulating Snail, E-cadherin and mesoderm-associated genes including Brachyury and Tbx6. Fate and movement are experimentally separable, even though a regulator can influence both.^[ref]

The cells contributing to definitive endoderm activate factors including SOX17 and FOXA2 and insert into the outer endodermal epithelium; mesoderm spreads between endoderm and the remaining epiblast. Earlier or more anterior streak contributions include axial and anterior mesendoderm, while other positions and times supply paraxial, lateral, cardiac and extraembryonic mesodermal populations. These associations are a dynamic fate map, not proof that every pre-streak cell is irreversibly determined. Stronger or more prolonged Nodal/SMAD activity supports particular anterior mesendoderm and definitive-endoderm contributions in a context-dependent manner. Conditional SMAD2 loss can preserve streak formation and gastrulation movements while disrupting anterior definitive endoderm and prechordal progenitor specification, directly distinguishing fate choice from a general inability to gastrulate.^[ref]

The epiblast remaining outside the ingressing populations forms ectoderm. Its neural versus surface-ectoderm choices depend on the local balance of BMP, FGF and antagonistic organizer-derived signals, alongside the timing of competence. Posterior progenitors can continue to supply neural and mesodermal tissues during axis elongation, so gastrulation is not one instantaneous partition of a homogeneous sheet. Nor does primitive endoderm simply become the entire embryonic gut: definitive endoderm formation and intercalation must be followed by lineage tracing. Conversely, visceral endoderm descendants are not all excluded from the gut epithelium: direct tracing demonstrates intercalation of embryonic and extraembryonic histories.^[ref] To test the proposed sequence, timed genetic perturbations should be paired with live imaging, endogenous lineage-marker combinations and descendant tracing. Mosaic or tissue-restricted perturbation distinguishes an epiblast-autonomous requirement from loss of a supporting extraembryonic signal, and measurements of proliferation and apoptosis prevent altered cell numbers from being mistaken for fate conversion. The central mechanism is reciprocal signalling acting on a changing, polarized and competent epiblast, with cell movements both implementing and modifying the resulting pattern.

An organism contains genetic elements and cell lineages whose transmission interests need not coincide. Conflict arises when increasing an element's representation in descendants or within the body differs from maximizing the organism's reproductive success. Shared residence does not guarantee shared evolutionary interests, but neither does every difference between genes constitute conflict. A convincing account identifies the competing lineages, their transmission routes, and the outcomes favoured by selection on each.

Ordinary Mendelian segregation helps align the interests of unlinked nuclear loci: most depend on the same successful organism and receive an approximately equal chance of entering its gametes. intragenomic conflict becomes possible when an element bypasses that shared route, biases transmission, replicates within the genome, or has a parent-specific effect on relatives. mutation supplies variation; genetic linkage can protect combinations involved in distortion, while recombination and selection at other loci can favour suppression. The fitness currency of a selfish genetic element is therefore its own propagation, not the apparent health or fecundity of its carrier.

meiotic drive provides a direct example. For a rare autosomal driver with transmission probabilities $t_f$ through heterozygous females and $t_m$ through heterozygous males, suppose, for illustration, that heterozygotes have the same viability factor $1-s$ in both sexes. With random mating and otherwise equal reproductive contributions, the rare-driver approximation is:A rare driver can increase when the multiplier exceeds one, despite a carrier cost. This accounting also shows why the sex in which drive occurs matters: with unbiased male transmission, $t_m=1/2$, not $t_m=t_f$. The approximation omits dominance in common genotypes, sex-specific fertility, linkage and suppressors; it is an explanatory invasion calculation rather than a quantitative model of every natural driver.

Asymmetric female meiosis creates one route to distortion because some products become eggs and others are discarded. In monkeyflowers, a centromere-associated allele showed a strong female transmission advantage, with male fertility costs that expose a conflict between transmission and organismal performance. ^[ref] Reciprocal crosses and appropriate genetic backgrounds are important: distorted counts among surviving offspring can result from embryonic viability differences rather than biased segregation. Direct observation or genotyping of gametes and early embryos helps identify the stage. centromere drive is consequently more specific than merely observing segregation distortion.

The evolutionary response can include drive suppressors at other loci. Suppression is favoured when restoring fair transmission or reducing fertility costs improves the propagation of the rest of the genome. Its effect depends on linkage: a modifier tightly associated with the driver can experience different selection from an unlinked modifier. Arms races can maintain polymorphism and alter reproductive mechanisms; conversely, a successful suppressor can conceal an earlier conflict. Present-day Mendelian ratios therefore do not establish that transmission has always been conflict-free.

Transposable elements exploit another route: copying or moving genetic material within a lineage. McClintock's maize experiments established mobile controlling elements through genetic and cytological observations, providing foundational evidence that genomic components need not occupy fixed positions. ^[ref] Mobility itself is not proof that every element is harmful or selfish in every context. The conflict hypothesis requires a replication or transmission advantage alongside consequences for other genomic functions. Host silencing through mechanisms such as RNA interference and DNA methylation can constrain propagation, while some formerly mobile sequences acquire useful regulatory functions. Current usefulness and historical origin are different claims.

genomic imprinting illustrates conflict through expression rather than transmission distortion. Maternally and paternally inherited copies can differ in their relatedness to individuals affected by resource allocation. If a mother's future offspring are less likely to share the current father, a paternally inherited copy in the current offspring can place relatively less weight on those future maternal offspring. kinship theory of genomic imprinting therefore predicts disagreement over resource extraction under specified mating and life-history assumptions. It does not predict opposed interests at every locus or in every mating system. ^[ref]

Targeted disruption of the mouse insulin-like growth factor 2 gene produced growth effects dependent on parental transmission, demonstrating parent-of-origin-dependent regulation of an important growth factor. ^[ref] This is mechanistic evidence for imprinting. It is not, by itself, proof that parental genetic conflict caused the evolutionary origin of that regulatory pattern. Testing that explanation requires comparisons among related species and mating systems, tissue-specific expression, effects on maternal and offspring fitness, and alternatives such as dosage regulation or coadaptation. The genetic copy's interest must not be confused with a father's conscious preference or with a universal claim that larger offspring are always better for one parent.

The broader category also includes conflicts between distinct genomes residing in one individual. cytoplasmic inheritance can make an organelle or microbial symbiont depend mainly on female transmission, whereas nuclear loci are ordinarily transmitted through both sexes. A maternally inherited symbiont can consequently spread through changes to reproduction that do not benefit every host. In Nasonia wasps, reciprocal crossing, chromosome observations and antibiotic removal connected cytoplasmic microorganisms to reproductive incompatibility and abnormal paternal chromosome condensation. ^[ref] This demonstrates a microbial cause of a barrier under those conditions, not necessarily the origin of every species difference. Antibiotic effects on host condition and other microbes require controls, and reintroduction experiments would strengthen microbial specificity.

somatic evolution is a related conflict at a different level. A mutant cell lineage can increase within a body by avoiding growth restraint or cell death while damaging the organism. Analyses of cancer genomes and normal somatic tissues identified patterns of selection on somatic mutations, showing that cellular success is an evolutionary quantity distinct from organismal success. ^[ref] Not all cell proliferation is selfish, and some detected mutations are passengers. Mutation-rate heterogeneity, tissue composition and sequencing ascertainment must be modelled before an excess of mutations is interpreted as selection.

Such conflicts have consequences beyond immediate harm. They can favour fair-segregation mechanisms, genome defence, regulated cell proliferation and restrictions on which cell lineages produce offspring. A single-cell bottleneck and germ-soma separation can increase alignment among cellular descendants or limit transmission of within-body competitors, although neither prevents new mutations. Conflict can also affect fertility, sex ratios, reproductive isolation and genome organization. Claims that it produced a particular major evolutionary change require historical and comparative evidence in addition to a plausible selective argument.

Organismal integration is partly an evolved outcome of controlling conflict, not evidence that conflict is absent. The strongest explanations connect a specific transmission asymmetry to an element's advantage, a measurable cost or opposed interest, and an experimentally or comparatively supported response.

Quiescence is a reversible nonproliferating cellular state, often designated $G_0$, from which suitable signals can permit re-entry into the cell cycle. A biological cell in quiescence can retain active metabolism, maintain its specialized functions and respond to its environment. This distinguishes quiescence from cell death and from irreversible loss of proliferative capacity. For example, some resting lymphocytes resume cell proliferation after activation. ^[ref]

A stress response is a coordinated change in cellular activity caused by conditions that threaten normal function, such as excessive temperature, nutrient shortage or damaged proteins. It can alter gene expression, protein degradation and metabolism. For example, increased production of molecular chaperones helps handle unfolded proteins. The response is protective only within limits: prolonged or severe stress can cause cell death. Measuring response markers therefore establishes detection of stress, not necessarily successful recovery. ^[ref]

Tumor necrosis factor, abbreviated TNF and also called TNF-alpha, is a signalling cytokine acting through cell-surface receptors. It occurs in membrane-associated and soluble forms, is produced prominently by macrophages, and can induce cell death in susceptible tumour cells. The biological outcome depends on the responding cells and signalling context.^[ref]

Its name records an experimental discovery. In1975, investigators found that blood serum from mice first infected with BCG and then treated with endotoxin could cause necrosis in transplanted tumours. Tests indicated that the active material was a host-derived factor, rather than residual endotoxin. The authors proposed release from macrophages; that proposed cellular origin should be distinguished from their directly observed serum activity.^[ref]

An illuminating comparison was the different response of cultures: the preparation was toxic to two tested neoplastic cell lines but not to mouse embryo cultures. This separates a measurable activity from a universal property of all cells. The historical tumour assay identified a signalling substance; it did not establish that TNF kills every tumour or has only one physiological role.^[ref]